{
    "clinical_study": {
        "@rank": "111089", 
        "arm_group": {
            "arm_group_label": "all eligible patients", 
            "description": "Treatment with Picato according to Summary of Product Characteristics (SmPC)"
        }, 
        "brief_summary": {
            "textblock": "Assessment of treatment success and quality of life in patients with actinic keratoses under\n      therapy with Ingenol Mebutate (Picato) in a period of 8 weeks."
        }, 
        "brief_title": "Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Actinic Keratosis", 
        "condition_browse": {
            "mesh_term": [
                "Keratosis", 
                "Keratosis, Actinic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Non-interventional (observational) study (NIS), non-controlled, prospective cohort study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        \u2022 Non-hyperkeratotic, non-hypertrophic actinic keratoses where treatment with Picato\u00ae is\n        indicated and the treatment is intended by physicians.\n\n        Exclusion Criteria:\n\n          -  Preceding use of Picato\u00ae on the area planned for treatment\n\n          -  Any other specific local treatment of actinic keratoses on the area planned for\n             treatment during the last 8 weeks\n\n          -  Melanoma, squamous cell carcinoma or spinalioma on the area planned for treatment\n\n          -  Open wounds on the area planned for treatment\n\n          -  Contraindications according to prescribing information"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients with actinic keratosis contacting their dermatologist"
            }
        }, 
        "enrollment": {
            "#text": "1080", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02090465", 
            "org_study_id": "DE-Picato NIS-2013"
        }, 
        "intervention": {
            "arm_group_label": "all eligible patients", 
            "description": "No intervention: observation of routine use of Picato\u00ae", 
            "intervention_name": "Ingenol Mebutate", 
            "intervention_type": "Drug", 
            "other_name": "Picato\u00ae"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Actinic Keratosis", 
        "lastchanged_date": "March 17, 2014", 
        "location": {
            "contact": {
                "email": "thomas.diepgen@med.uni-heidelberg.de", 
                "last_name": "Thomas L. Diepgen, Prof.Dr.med.", 
                "phone": "+49 6221568751"
            }, 
            "facility": {
                "address": {
                    "city": "Heidelberg", 
                    "country": "Germany", 
                    "zip": "D-69115"
                }, 
                "name": "Universit\u00e4tsklinikum Heidelberg/Klinische Sozialmedizin"
            }, 
            "investigator": {
                "last_name": "Thomas L Diepgen, Prof.Dr.med.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate (Picato) in a Period of 8 Weeks.", 
        "overall_contact": {
            "email": "andreas.gilzinger@leo-pharma.com", 
            "last_name": "Andreas Gilzinger", 
            "phone": "0049 6102 201-0", 
            "phone_ext": "117"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Heidelberg", 
            "last_name": "Thomas Diepgen, Prof. Dr. med.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Documentation of the course of actinic keratoses and skin findings during ambulant routine use of Picato\u00ae", 
                "measure": "Actinic keratosis", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Patient' s quality of life during ambulant routine use of Picato\u00ae", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Prescribed and applied dosages and adherence during ambulant routine use of Picato\u00ae", 
                "measure": "Dosage of Picato\u00ae", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02090465"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "LEO Pharma", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LEO Pharma", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}